Learning Objectives:
1. Describe the underlying pathophysiological mechanisms of gait impairment and freezing of gait in Parkinson’s disease, highlighting the role of non-dopaminergic contributors
2. Critically evaluate the utility, limitations, and future direction of wearable technologies and digital biomarkers for objective gait analysis in Parkinson’s disease
3. Discuss current evidence supporting non-pharmacological interventions for improving gait and balance in Parkinson’s disease, including digital technologies and robotic-assisted rehabilitation